GOLD 2017 recommendations for COPD patients: toward a more personalized approach. COPD Res Pract. 2017;3(1):5.S. Roversi, L. Corbetta, and E. Clini, "GOLD 2017 recom- mendations for COPD patients: toward a more personalized approach," COPD Research and Practice, vol. 3, no. 5, 2017...
23-25 The pathophysiology of COPD lends itself to reduced immune function within the pulmonary system and an inability to adequately recover following respiratory infections.23,25 Effectiveness of influenza vaccinations in reducing negative outcomes from infection in patients with COPD is no...
The changes in grading of disease severity and treatment recommendations for patients with COPD in the 2017 GOLD strategy may present an opportunity for reducing treatment burden for the patients and costs to the health care system. The aim of this study was to assess the implications of the GOL...
2B 3.21 For COPD patients under invasive ventilation who exhibit signs of failure after exbutation, the consideration of non-invasive positive ventilator therapy to assist in the weaning of the ventilator in those who do not have relevant contraindications is recommended as it may prevent re-intubat...
Figure 3 summarizes features that are useful in distinguishing asthma from COPD. Fig. 3: Approach to initial treatment in patients with asthma and/or COPD. GOLD Global Initiative for Obstructive Lung Disease, ICS inhaled corticosteroid, LABA long-acting β2 agonist; LAMA long-acting muscarinic ...
A qualitative study of televideo consultations for COPD patients Br J Nurs, 24 (4) (2015), pp. 205-9 10.12968/bjon.2015.24.4.205 25723262 CrossrefView in ScopusGoogle Scholar 184. R McCloskey, P Jarrett, C Stewart, L Keeping-Burke Recruitment and retention challenges in a technology-based...
French radiotherapy departments therefore need to move towards more adapted and scalable validation whilst maintaining meticulous planning and the close monitoring of patients for the early detection and management of potential toxicity. The limitations of the national survey include the lack of ...
Figure 3 summarizes features that are useful in distinguishing asthma from COPD. Fig. 3: Approach to initial treatment in patients with asthma and/or COPD. GOLD Global Initiative for Obstructive Lung Disease, ICS inhaled corticosteroid, LABA long-acting β2 agonist; LAMA long-acting muscarinic ...
Elsewhere the SMC gave positive to two drugs for use in respiratory conditions. GlaxoSmithKline’s (GSK) Incruse (umeclidinium) is now available to adult NHS Scotland patients with chronic obstructive pulmonary disease (COPD). COPD patients will also have access to Novartis’ Ulibro Breezhaler, a ...